Related Experiment Video
Updated: Oct 17, 2025

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
[Research progress on screening of pregnancy-related diseases based on fetal cell free DNA]
Jianan Liu1, Geng An, Yanhui Liu
1Reproductive Medicine Center, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510150, China. liuliang71215@163.com.
Abstract:
Fetal cell free DNA (cfDNA) in maternal blood circulation mainly originates from placental trophoblasts which have dual characteristics of apoptotic cells and the embryo, and can be affected by maternal factors. Pregnancy-related diseases including preeclampsia, gestational diabetes mellitus, preeclampsia, macrosomia and fetal growth restriction can seriously affect maternal health and pregnancy outcome. Early prediction and timely intervention are important means to reduce the risk. Fetal cfDNA and prediction of pregnancy-related diseases have become a hot topicfor current research. This paper reviews the latest progress made in the field.

